Revenue Breakdown
Composition ()
No data
Revenue Streams
Strata Critical Medical Inc (SRTA) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Other, accounting for 63.7% of total sales, equivalent to $45.11M. Other significant revenue streams include Short Distance and MediMobility Organ Transport and Jet. Understanding this composition is critical for investors evaluating how SRTA navigates market cycles within the Online Services industry.
Profitability & Margins
Evaluating the bottom line, Strata Critical Medical Inc maintains a gross margin of 23.56%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -11.40%, while the net margin is -19.59%. These profitability ratios, combined with a Return on Equity (ROE) of -12.88%, provide a clear picture of how effectively SRTA converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, SRTA competes directly with industry leaders such as AUNA and DNA. With a market capitalization of $387.79M, it holds a significant position in the sector. When comparing efficiency, SRTA's gross margin of 23.56% stands against AUNA's 37.52% and DNA's 67.04%. Such benchmarking helps identify whether Strata Critical Medical Inc is trading at a premium or discount relative to its financial performance.
